DIFFUSIO2N
Live / Applied — Fourth extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 18 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97508583
- Mark type
- Word mark
- Filed
- 18 Jul 2022
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Marya K. Jones
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals
Owner
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
Prosecution history
- 09 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 4 GRANTED
- 13 Feb 2026 — SOU EXTENSION 4 FILED
- 09 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 17 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 17 Feb 2026 — PETITION TO REVIVE-GRANTED
- 17 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 3 GRANTED
- 12 Aug 2025 — SOU EXTENSION 3 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 2 GRANTED
- 13 Feb 2025 — SOU EXTENSION 2 FILED